PORTAL-PTSD for Post-Traumatic Stress Disorder (PORTAL-PTSD Trial)

N/A

Recruiting

Led By Neda Laiteerapong, MD, MS

Research Sponsored by University of Chicago

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age ≥18 years

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up every 6 months post-intervention for 2 years

Awards & highlights

No Placebo-Only Group

Summary

"This trial aims to improve the diagnosis and management of post-traumatic stress disorder (PTSD) in a primary care setting in South Side of Chicago. It will be done in collaboration with Chicago Family Health

Who is the study for?

This trial is for individuals who may have post-traumatic stress disorder (PTSD) and are receiving care in a primary care setting on the South Side of Chicago. The study is looking to include those who could benefit from a new approach to PTSD diagnosis and management.

What is being tested?

The PORTAL-PTSD intervention, which aims to improve the timeliness of PTSD diagnosis and treatment, is being tested among patients at the Chicago Family Health Center.

What are the potential side effects?

Since PORTAL-PTSD involves diagnostic and management strategies rather than medication or invasive procedures, traditional side effects are not applicable. However, participants might experience discomfort discussing traumatic events.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ every 6 months post-intervention for 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~every 6 months post-intervention for 2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and every 6 months post-intervention for 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

PTSD diagnoses rates

PTSD prescribed treatment rates

PTSD screening rates

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: PORTAL-PTSD InterventionExperimental Treatment1 Intervention

Chicago Family Health Center clinics are randomly assigned to any of the 5 steps. The PORTAL-PTSD intervention is implemented after clinic staff and clinicians have been trained.

Group II: No PORTAL-PTSD InterventionActive Control1 Intervention

Standard of care offered to all patients

0 / 1Eligibility criteria met